Szántai-Kis C - Search Results

1

Discovery and development of extreme selective inhibitors of the ITD and D835Y mutant FLT3 kinases.

Baska F, Sipos A, Őrfi Z, Nemes Z, Dobos J, Szántai-Kis C, Szabó E, Szénási G, Dézsi L, Hamar P, Cserepes MT, Tóvári J, Garamvölgyi R, Krekó M, Őrfi L. Baska F, et al. Among authors: szantai kis c. Eur J Med Chem. 2019 Dec 15;184:111710. doi: 10.1016/j.ejmech.2019.111710. Epub 2019 Oct 5. Eur J Med Chem. 2019. PMID: 31614258

2

Design and synthesis of new imidazo[1,2-a]pyridine and imidazo[1,2-a]pyrazine derivatives with antiproliferative activity against melanoma cells.

Garamvölgyi R, Dobos J, Sipos A, Boros S, Illyés E, Baska F, Kékesi L, Szabadkai I, Szántai-Kis C, Kéri G, Őrfi L. Garamvölgyi R, et al. Among authors: szantai kis c. Eur J Med Chem. 2016 Jan 27;108:623-643. doi: 10.1016/j.ejmech.2015.12.001. Epub 2015 Dec 12. Eur J Med Chem. 2016. PMID: 26724730

3

Novel compounds with potent CDK9 inhibitory activity for the treatment of myeloma.

Czudor Z, Balogh M, Bánhegyi P, Boros S, Breza N, Dobos J, Fábián M, Horváth Z, Illyés E, Markó P, Sipos A, Szántai-Kis C, Szokol B, Őrfi L. Czudor Z, et al. Among authors: szantai kis c. Bioorg Med Chem Lett. 2018 Feb 15;28(4):769-773. doi: 10.1016/j.bmcl.2018.01.002. Epub 2018 Jan 2. Bioorg Med Chem Lett. 2018. PMID: 29329658

4

Synthesis and characterization of amino acid substituted sunitinib analogues for the treatment of AML.

Nemes Z, Takács-Novák K, Völgyi G, Valko K, Béni S, Horváth Z, Szokol B, Breza N, Dobos J, Szántai-Kis C, Illyés E, Boros S, Kok RJ, Őrfi L. Nemes Z, et al. Among authors: szantai kis c. Bioorg Med Chem Lett. 2018 Aug 1;28(14):2391-2398. doi: 10.1016/j.bmcl.2018.06.026. Epub 2018 Jun 18. Bioorg Med Chem Lett. 2018. PMID: 29935772

5

Discovery and Biological Evaluation of Novel Dual EGFR/c-Met Inhibitors.

Szokol B, Gyulavári P, Kurkó I, Baska F, Szántai-Kis C, Greff Z, Orfi Z, Peták I, Pénzes K, Torka R, Ullrich A, Orfi L, Vántus T, Kéri G. Szokol B, et al. ACS Med Chem Lett. 2014 Jan 30;5(4):298-303. doi: 10.1021/ml4003309. eCollection 2014 Apr 10. ACS Med Chem Lett. 2014. PMID: 24900830 Free PMC article.

6

Development of a 3D Tissue Culture-Based High-Content Screening Platform That Uses Phenotypic Profiling to Discriminate Selective Inhibitors of Receptor Tyrosine Kinases.

Booij TH, Klop MJ, Yan K, Szántai-Kis C, Szokol B, Orfi L, van de Water B, Keri G, Price LS. Booij TH, et al. Among authors: szantai kis c. J Biomol Screen. 2016 Oct;21(9):912-22. doi: 10.1177/1087057116657269. Epub 2016 Jul 7. J Biomol Screen. 2016. PMID: 27412535 Free PMC article.

7

Discovery and optimization of novel benzothiophene-3-carboxamides as highly potent inhibitors of Aurora kinases A and B.

Gyulavári P, Szokol B, Szabadkai I, Brauswetter D, Bánhegyi P, Varga A, Markó P, Boros S, Illyés E, Szántai-Kis C, Krekó M, Czudor Z, Őrfi L. Gyulavári P, et al. Among authors: szantai kis c. Bioorg Med Chem Lett. 2018 Oct 15;28(19):3265-3270. doi: 10.1016/j.bmcl.2018.05.064. Epub 2018 Jun 1. Bioorg Med Chem Lett. 2018. PMID: 30143423

8

[Developing FGFR inhibitors as potential anti-cancer agents].

Zsákai L, Németh G, Szántai-Kis C, Greff Z, Horváth Z, Szokol B, Baska F, Boon TC, Orfi L, Kéri G. Zsákai L, et al. Acta Pharm Hung. 2013;83(2):47-56. Acta Pharm Hung. 2013. PMID: 23926649 Hungarian.

9

Lead selection and characterization of antitubercular compounds using the Nested Chemical Library.

Sipos A, Pató J, Székely R, Hartkoorn RC, Kékesi L, Őrfi L, Szántai-Kis C, Mikušová K, Svetlíková Z, Korduláková J, Nagaraja V, Godbole AA, Bush N, Collin F, Maxwell A, Cole ST, Kéri G. Sipos A, et al. Tuberculosis (Edinb). 2015 Jun;95 Suppl 1:S200-6. doi: 10.1016/j.tube.2015.02.028. Epub 2015 Feb 28. Tuberculosis (Edinb). 2015. PMID: 25801335

10

Novel compounds reducing IRS-1 serine phosphorylation for treatment of diabetes.

Simon-Szabó L, Kokas M, Greff Z, Boros S, Bánhegyi P, Zsákai L, Szántai-Kis C, Vantus T, Mandl J, Bánhegyi G, Vályi-Nagy I, Őrfi L, Ullrich A, Csala M, Kéri G. Simon-Szabó L, et al. Among authors: szantai kis c. Bioorg Med Chem Lett. 2016 Jan 15;26(2):424-428. doi: 10.1016/j.bmcl.2015.11.099. Epub 2015 Nov 28. Bioorg Med Chem Lett. 2016. PMID: 26704265

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

28 results

Search Page